Near- and forecasting the SARS-COV-2 epidemic requires a global view and multiple methods
View ORCID ProfileDaren Austin
doi: https://doi.org/10.1101/2020.04.09.20059402
Daren Austin
1Senior Fellow, Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline Research and Development, Email: , Phone: +447712 670097
PhD ARCS DICArticle usage
Posted April 14, 2020.
Near- and forecasting the SARS-COV-2 epidemic requires a global view and multiple methods
Daren Austin
medRxiv 2020.04.09.20059402; doi: https://doi.org/10.1101/2020.04.09.20059402
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2908)
- Dermatology (249)
- Emergency Medicine (436)
- Epidemiology (12679)
- Forensic Medicine (10)
- Gastroenterology (823)
- Genetic and Genomic Medicine (4534)
- Geriatric Medicine (412)
- Health Economics (723)
- Health Informatics (2897)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (918)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4302)
- Nursing (233)
- Nutrition (631)
- Oncology (2250)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1192)
- Primary Care Research (491)
- Public and Global Health (6884)
- Radiology and Imaging (1515)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (207)
- Urology (178)